BluePrintBio
Newport Beach
About BluePrintBio
Personalized medicine is about getting the right treatments to the right people at the right time. We believe that this requires a quantum leap in technology and know-how. By aligning ourselves with the right scientists, data analysis experts, and thought leaders we can identify and bring to market solutions that will fulfill the promise of personalized medicine.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $8.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Apr 2017)
- Website: blueprintbio.com
Industries & Categories
Biopharma, Health Care, Medical Device, Precision Medicine
Canonical: https://fsome.com/organization/blueprintbio-2234747 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.